Medline Inc.
corporate_fare Company Profile
Medline Inc. (NASDAQ:MDLN) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 36 items for MDLN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-13, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for MDLN spans 8-K, 4, 424B4, S-1MEF.
Recent high-impact activity:
- FDA Flags Medline Kits Over Contaminated BD Applicators
- Medline Q2 Profit Plunges 58% on $336M Fire Charge, Cuts EBITDA Outlook
- Medline Q2 Sales Surge 11.6% but Net Income Plunges 58% on Fire Loss; Guidance Mixed
- Medline COO Stephen Miller to Retire for Health Reasons, Successor Search Underway
- Medline Secures Prime Vendor Agreement with Allina Health
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for MDLN, detected from its recent SEC filings · based on capital-structure filings through 2026-05-26.
Secondary Offering Finalized · No Proceeds to Company
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →